5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.40▼ | 0.40▼ | 0.40▼ | 0.39▲ | 0.44▼ |
MA10 | 0.40▼ | 0.39▼ | 0.39▼ | 0.40▼ | 0.38▲ |
MA20 | 0.39▲ | 0.39▼ | 0.39▼ | 0.45▼ | 0.52▼ |
MA50 | 0.39▲ | 0.39▲ | 0.39▼ | 0.41▼ | 0.78▼ |
MA100 | 0.40▼ | 0.41▼ | 0.45▼ | 0.55▼ | 1.21▼ |
MA200 | 0.41▼ | 0.45▼ | 0.41▼ | 0.74▼ | 13.33▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.001▲ | 0.001▲ | -0.008▼ | 0.009▲ |
RSI | 50.074▲ | 49.734▼ | 48.505▼ | 45.366▼ | 38.516▼ |
STOCH | 72.433 | 78.117 | 71.599 | 29.199 | 39.829 |
WILL %R | -54.396 | -47.143 | -50.224 | -88.878▼ | -67.537 |
CCI | -14.433 | 12.994 | -15.647 | -51.499 | -49.702 |
Thursday, August 14, 2025 05:40 AM
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...
|
Wednesday, August 06, 2025 05:09 AM
Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the Positive FDA Meeting GLEN ALLEN, Va., Aug. 06, 2025 (GLOBE NEWSWIRE) -- ...
|
Wednesday, July 16, 2025 06:44 AM
Adial Pharmaceuticals (ADIL) has announced that it has regained compliance with Nasdaq Listing Rule 5550 (b) (1). The company received notification on July 14, 2025, confirming it now meets the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 0.389 | 0.4099 | 0.3815 | 0.394 | 669,381 |
14/08/25 | 0.3841 | 0.40 | 0.3764 | 0.3945 | 823,842 |
13/08/25 | 0.395 | 0.4156 | 0.3914 | 0.40 | 689,391 |
12/08/25 | 0.3725 | 0.3982 | 0.37 | 0.395 | 586,116 |
11/08/25 | 0.36 | 0.3838 | 0.3487 | 0.3743 | 712,727 |
08/08/25 | 0.38 | 0.3974 | 0.367 | 0.3799 | 1,049,584 |
07/08/25 | 0.3921 | 0.40 | 0.3814 | 0.387 | 1,218,811 |
06/08/25 | 0.442 | 0.459 | 0.3957 | 0.4128 | 1,932,393 |
05/08/25 | 0.401 | 0.44 | 0.401 | 0.434 | 742,838 |
04/08/25 | 0.4021 | 0.435 | 0.40 | 0.4154 | 1,312,657 |
|
|
||||
|
|
||||
|
|